BTG and Society of Interventional Oncology to explore role of minimally invasive therapies in immuno-oncology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

BTG plc announced a collaboration with the Society of Interventional Oncology, a global organization working to nurture and support interventional oncology worldwide, to explore the role of interventional oncology alongside immuno-oncology.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe

YOU MAY BE INTERESTED IN

Login